- Home
- ESPR vs PNRG Comparison
ESPR vs PNRG Comparison
Compare ESPR & PNRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- PNRG
- Stock Information
- Founded
- ESPR 2008
- PNRG 1973
- Country
- ESPR United States
- PNRG United States
- Employees
- ESPR N/A
- PNRG N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- PNRG Oil & Gas Production
- Sector
- ESPR Health Care
- PNRG Energy
- Exchange
- ESPR Nasdaq
- PNRG Nasdaq
- Market Cap
- ESPR 399.0M
- PNRG 355.8M
- IPO Year
- ESPR 2013
- PNRG N/A
- Fundamental
- Price
- ESPR $2.32
- PNRG $227.00
- Analyst Decision
- ESPR Buy
- PNRG
- Analyst Count
- ESPR 5
- PNRG 0
- Target Price
- ESPR $7.30
- PNRG N/A
- AVG Volume (30 Days)
- ESPR 8.5M
- PNRG 8.2K
- Earning Date
- ESPR 11-07-2024
- PNRG 11-14-2024
- Dividend Yield
- ESPR N/A
- PNRG N/A
- EPS Growth
- ESPR N/A
- PNRG 71.12
- EPS
- ESPR N/A
- PNRG 23.14
- Revenue
- ESPR $295,451,000.00
- PNRG $210,064,000.00
- Revenue This Year
- ESPR $186.90
- PNRG N/A
- Revenue Next Year
- ESPR $31.10
- PNRG N/A
- P/E Ratio
- ESPR N/A
- PNRG $8.69
- Revenue Growth
- ESPR 187.12
- PNRG 88.03
- 52 Week Low
- ESPR $1.58
- PNRG $92.40
- 52 Week High
- ESPR $3.94
- PNRG $227.81
- Technical
- Relative Strength Index (RSI)
- ESPR 45.30
- PNRG 67.57
- Support Level
- ESPR $2.12
- PNRG $163.77
- Resistance Level
- ESPR $2.54
- PNRG $220.50
- Average True Range (ATR)
- ESPR 0.33
- PNRG 12.61
- MACD
- ESPR -0.09
- PNRG 1.41
- Stochastic Oscillator
- ESPR 22.86
- PNRG 98.74
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About PNRG PrimeEnergy Resources Corporation
PrimeEnergy Resources Corp is an independent oil and natural gas company that is engaged in acquiring, developing, and producing oil and natural gas. It owns producing and non-producing properties located in Texas and Oklahoma. The company's business activities include development and exploratory drilling and provide well servicing support operations for many of the onshore oil and gas wells through its subsidiaries. It is also active in the acquisition of producing oil and gas properties through joint ventures with industry partners.